Wealthspire Advisors (Maryland)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $1.42M | Buy |
3,209
+32
| +1% | +$14.1K | 0.05% | 157 |
|
|
2020
Q2 | $1.15M | Sell |
3,177
-12
| -0.4% | -$4.35K | 0.08% | 145 |
|
|
2020
Q1 | $904K | Buy |
3,189
+121
| +4% | +$34.3K | 0.08% | 146 |
|
|
2019
Q4 | $997K | Buy |
3,068
+193
| +7% | +$62.7K | 0.07% | 171 |
|
|
2019
Q3 | $837K | Buy |
2,875
+145
| +5% | +$42.2K | 0.06% | 168 |
|
|
2019
Q2 | $802K | Buy |
2,730
+198
| +8% | +$58.2K | 0.06% | 168 |
|
|
2019
Q1 | $693K | Sell |
2,532
-414
| -14% | -$113K | 0.05% | 198 |
|
|
2018
Q4 | $659K | Buy |
2,946
+20
| +0.7% | +$4.47K | 0.06% | 175 |
|
|
2018
Q3 | $714K | Buy |
2,926
+319
| +12% | +$77.8K | 0.06% | 183 |
|
|
2018
Q2 | $540K | Buy |
2,607
+45
| +2% | +$9.32K | 0.05% | 221 |
|
|
2018
Q1 | $529K | Sell |
2,562
-178
| -6% | -$36.8K | 0.05% | 235 |
|
|
2017
Q4 | $520K | Sell |
2,740
-247
| -8% | -$46.9K | 0.05% | 247 |
|
|
2017
Q3 | $565K | Buy |
2,987
+268
| +10% | +$50.7K | 0.06% | 219 |
|
|
2017
Q2 | $474K | Buy |
2,719
+164
| +6% | +$28.6K | 0.06% | 238 |
|
|
2017
Q1 | $392K | Sell |
2,555
-313
| -11% | -$48K | 0.06% | 233 |
|
|
2016
Q4 | $405K | Buy |
2,868
+463
| +19% | +$65.4K | 0.06% | 210 |
|
|
2016
Q3 | $383K | Sell |
2,405
-41
| -2% | -$6.53K | 0.06% | 220 |
|
|
2016
Q2 | $361K | Buy |
2,446
+313
| +15% | +$46.2K | 0.06% | 217 |
|
|
2016
Q1 | $302K | Sell |
2,133
-176
| -8% | -$24.9K | 0.05% | 252 |
|
|
2015
Q4 | $328K | Buy |
+2,309
| New | +$328K | 0.06% | 235 |
|